Fate Therapeutics Inc (FATE)

03:46 AM

Price T Rowe Associates Inc. MD Cuts Stock Position in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

03:46 AM

May 17, 2025

StockNews.com Upgrades Fate Therapeutics (NASDAQ:FATE) to Hold - Defense World

May 17, 2025

May 17, 2025

Barclays Cuts Fate Therapeutics (NASDAQ:FATE) Price Target to $2.00 - Defense World

May 17, 2025

May 17, 2025

Wedbush Predicts Increased Earnings for Fate Therapeutics - Defense World

May 17, 2025

May 17, 2025

What is Leerink Partnrs’ Estimate for FATE Q2 Earnings? - Defense World

May 17, 2025

May 16, 2025

Fate Therapeutics' Q1 Earnings & Revenues Beat, Pipeline in Focus - MSN

May 16, 2025

May 16, 2025

Needham & Company LLC Reiterates “Hold” Rating for Fate Therapeutics (NASDAQ:FATE) - Defense World

May 16, 2025

May 15, 2025

Fate Therapeutics First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025

May 15, 2025

Fate Therapeutics (FATE) Faces Significant Price Target Reductio - GuruFocus

May 15, 2025

May 14, 2025

FATE Stock Update: Analyst Lowers Price Target, Maintains Neutra - GuruFocus

May 14, 2025

May 14, 2025

4 Analysts Assess Fate Therapeutics: What You Need To Know - Benzinga

May 14, 2025

May 14, 2025

Barclays Adjusts Fate Therapeutics (FATE) Price Target Amid Q1 R - GuruFocus

May 14, 2025

May 14, 2025

Baird Revises Fate Therapeutics (FATE) Price Target Post-Q1 Resu - GuruFocus

May 14, 2025

May 14, 2025

FATE Therapeutics Exceeds Revenue Estimates with Strong CAR T-Ce - GuruFocus

May 14, 2025

May 14, 2025

Fate Therapeutics: Q1 Earnings Snapshot - CT Insider

May 14, 2025

May 14, 2025

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 14, 2025

May 13, 2025

Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - The Manila Times

May 13, 2025

May 13, 2025

FATE THERAPEUTICS INC SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

What Is Going On With Fate Therapeutics Inc (NASDAQ: FATE)? - Stocksregister

May 13, 2025

May 13, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 13, 2025

May 12, 2025

Hsbc Holdings PLC Has $179,000 Stock Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

May 12, 2025

May 11, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by MetLife Investment Management LLC - Defense World

May 11, 2025

May 10, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Purchased by Wells Fargo & Company MN - Defense World

May 10, 2025

May 08, 2025

Fate Therapeutics: Suffering The Fate Of A Depressed Cell Therapy Sector - Seeking Alpha

May 08, 2025

May 07, 2025

Fate Therapeutics Inc (NASDAQ: FATE) Drops -18.14 Percent In Recent Trading, What Questions Do You Have? - Stocksregister

May 07, 2025

May 05, 2025

Fate Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView

May 05, 2025

May 02, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 02, 2025

May 02, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of “Hold” by Brokerages - Defense World

May 02, 2025

May 01, 2025

Fate Therapeutics Inc [FATE] Records 50-Day SMA of $1.0480 - knoxdaily.com

May 01, 2025

May 01, 2025

LPL Financial LLC Buys New Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

May 01, 2025

Apr 30, 2025

Uncovering the Potential of Fate Therapeutics Inc (FATE) Stock - investchronicle.com

Apr 30, 2025

Apr 30, 2025

There is no way Fate Therapeutics Inc (FATE) can keep these numbers up - Sete News

Apr 30, 2025

Apr 29, 2025

Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting - The Manila Times

Apr 29, 2025

Apr 29, 2025

Fate Therapeutics to Present Clinical and Preclinical Data at ASGCT 28th Annual Meeting - Nasdaq

Apr 29, 2025

Apr 29, 2025

Was anything negative for Fate Therapeutics Inc (FATE) stock last session? - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Fate Therapeutics Announces Five Presentations on - GlobeNewswire

Apr 29, 2025

Apr 28, 2025

The Attractiveness of Investing In Fate Therapeutics Inc (FATE) is Growing - knoxdaily.com

Apr 28, 2025

Apr 28, 2025

Geode Capital Management LLC Sells 31,279 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 27, 2025

Recent uptick might appease Fate Therapeutics, Inc. (NASDAQ:FATE) institutional owners after losing 66% over the past year - Yahoo

Apr 27, 2025

Apr 26, 2025

Russell Investments Group Ltd. Increases Stock Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 26, 2025

Apr 25, 2025

FATE CLASS ACTION: Hagens Berman Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

FATE Shares Experience Decline in Value - knoxdaily.com

Apr 24, 2025

Apr 23, 2025

Analyzing Ratios: Fate Therapeutics Inc (FATE)’s Financial Story Unveiled - DWinneX

Apr 23, 2025

Apr 23, 2025

Ratios Revealed: Decoding Allarity Therapeutics Inc (ALLR)’s Financial Health - DWinneX

Apr 23, 2025

Apr 23, 2025

JPMorgan Chase & Co. Reduces Stock Position in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 23, 2025

Apr 22, 2025

Fate Therapeutics Inc [FATE] Stock trading around $1.25 per share: What’s Next? - dbtnews.com

Apr 22, 2025

Apr 22, 2025

Nothing is Better Than Fate Therapeutics Inc (FATE) stock at the moment - Sete News

Apr 22, 2025

Apr 21, 2025

Is Fate Therapeutics Inc (NASDAQ:FATE) stock a better investment at this time? - uspostnews.com

Apr 21, 2025

Apr 19, 2025

Franklin Resources Inc. Has $273,000 Stock Position in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 19, 2025

Apr 17, 2025

Vanguard Group Inc. Cuts Stake in Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 17, 2025